| Income Statement |
| Total Revenue | 46.50M |
|
| Revenues (USD) | 46.50M |
| Cost of Revenue | 26.70M |
| Gross Profit | 19.80M |
| Operating Expenses | 191.51M |
| Research and Development Expense | 440.00K |
| Selling, General and Administrative Expense | 12.88M |
| Operating Income | -171.71M |
| Interest Expense | 5.63M |
| Net Income | -176.94M |
| Net Income Common Stock | -176.94M |
| Net Income Common Stock (USD) | -176.94M |
| Consolidated Income | -176.26M |
| Net Income to Non-Controlling Interests | 680.00K |
| Earnings per Basic Share | -0.75 |
| Earnings per Basic Share (USD) | -0.75 |
| Earnings per Diluted Share | -0.75 |
| Earning Before Interest & Taxes (EBIT) | -171.31M |
| Earning Before Interest & Taxes (USD) | -171.31M |
| Weighted Average Shares | 237.05M |
| Weighted Average Shares Diluted | 237.05M |
| Balance Sheet |
| Cash and Equivalents | 58.15M |
| Cash and Equivalents (USD) | 58.15M |
| Trade and Non-Trade Receivables | 11.97M |
| Current Assets | 101.60M |
| Property, Plant & Equipment Net | 241.46M |
| Total Assets | 490.71M |
| Debt Current | 909.00K |
| Total Debt | 170.70M |
| Current Liabilities | 37.64M |
| Debt Non-Current | 169.79M |
| Total Liabilities | 209.76M |
| Accumulated Retained Earnings (Deficit) | -1.03B |
| Shareholders Equity | 273.16M |
| Shareholders Equity (USD) | 273.16M |
| Assets Non-Current | 389.11M |
| Total Debt (USD) | 170.70M |
| Goodwill and Intangible Assets | 115.15M |
| Inventory | 19.30M |
| Liabilities Non-Current | 172.12M |
| Trade and Non-Trade Payables | 33.39M |
| Tax Liabilities | 3.34M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 6.60M |
| Net Cash Flow from Financing | 14.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -20.75M |
| Capital Expenditure | -12.49M |
| Issuance (Purchase) of Equity Shares | 551.00K |
| Issuance (Repayment) of Debt Securities | 59.00K |
| Net Cash Flow from Investing | -12.49M |
| Net Cash Flow from Operations | -8.27M |
| Share Based Compensation | 2.56M |